(Q35685516)

9 August 2017

Pharmacokinetics of linezolid in subjects with renal dysfunction (English)

1 reference

9 August 2017

1 reference

1 reference

Michael E Brier

1

1 reference

9 August 2017

Dennis J Stalker

2

1 reference

9 August 2017

George R Aronoff

3

1 reference

9 August 2017

Donald H Batts

4

1 reference

9 August 2017

Kristi K Ryan

5

1 reference

9 August 2017

Margaret O'Grady

6

1 reference

9 August 2017

Nancy K Hopkins

7

1 reference

9 August 2017

Gail L Jungbluth

8

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

Antimicrobial Agents and Chemotherapy

9 August 2017

1 reference

9 August 2017

47

1 reference

9 August 2017

9

1 reference

9 August 2017

2775-2780

1 reference

Age and sex effects on the pharmacokinetics of linezolid

9 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182634

Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjects.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182634

A pharmacokinetic evaluation of concomitant administration of linezolid and aztreonam

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182634

Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182634

In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182634

Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compounds

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182634

Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compound

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182634

Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182634

The mechanism of action of DuP 721, a new antibacterial agent: effects on macromolecular synthesis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182634

Prediction of creatinine clearance from serum creatinine

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182634

Linezolid absolute bioavailability and the effect of food on oral bioavailability

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182634

Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=182634

Prevalence of vancomycin-resistant enterococci among children with end-stage renal failure. Mid-European Pediatric Peritoneal Dialysis Study Group

25 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12936973

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.47.9.2775-2780.2003

1 reference

9 August 2017

1 reference

9 August 2017

1 reference